| 0.6523 -0.021 (-3.1%) | 09-23 13:10 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.79 |
1-year : | 0.87 |
| Resists | First : | 0.68 |
Second : | 0.75 |
| Pivot price | 0.68 |
|||
| Supports | First : | 0.56 |
Second : | 0.47 |
| MAs | MA(5) : | 0.66 |
MA(20) : | 0.68 |
| MA(100) : | 0.71 |
MA(250) : | 1.06 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 22.4 |
D(3) : | 29 |
| RSI | RSI(14): 41.8 |
|||
| 52-week | High : | 2.06 | Low : | 0.55 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ SKIN ] has closed below the lower bollinger band by 2.0%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ SKIN ] is to continue within current trading range. It is unclear right now based on current values. 69.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 20 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.68 - 0.69 | 0.69 - 0.69 |
| Low: | 0.65 - 0.65 | 0.65 - 0.66 |
| Close: | 0.67 - 0.67 | 0.67 - 0.68 |
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.
Tue, 22 Sep 2026
SKIN: Stockholders voted on a reverse stock split and adjournment, with results to be filed in Form 8-K - TradingView
Sun, 20 Sep 2026
SkinHealth Systems Inc.(NasdaqCM: SKIN) dropped from S&P Global BMI Index - marketscreener.com
Tue, 15 Sep 2026
Every subject showed skin improvement after a monthly Hydrafacial series - Stock Titan
Thu, 10 Sep 2026
SkinHealth Systems promotes Michael Monahan to Chief Financial and Operating Officer - TradingView
Thu, 10 Sep 2026
SkinHealth Systems (SKIN) expands CFO role to operations - Stock Titan
Tue, 11 Aug 2026
SkinHealth Systems Inc. (SKIN) International Revenue Performance Explored - finance.yahoo.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Specialties
|
|
| Shares Out | 130 (M) |
| Shares Float | 56 (M) |
| Held by Insiders | 13 (%) |
| Held by Institutions | 77.1 (%) |
| Shares Short | 7,070 (K) |
| Shares Short P.Month | 8,750 (K) |
| EPS | -0.24 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.43 |
| Profit Margin | -9.9 % |
| Operating Margin | 4.9 % |
| Return on Assets (ttm) | -0.6 % |
| Return on Equity (ttm) | -43.9 % |
| Qtrly Rev. Growth | -7.9 % |
| Gross Profit (p.s.) | 1.47 |
| Sales Per Share | 2.22 |
| EBITDA (p.s.) | 0.15 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 22 (M) |
| Levered Free Cash Flow | 27 (M) |
| PE Ratio | -2.81 |
| PEG Ratio | 0.9 |
| Price to Book value | 1.5 |
| Price to Sales | 0.28 |
| Price to Cash Flow | 3.82 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|